Discovery of a novel, potent and selective human β3-adrenergic receptor agonist

Discovery of a novel, potent and selective human β3-adrenergic receptor agonist Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β₃-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β₃-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists A simplified template approach towards the synthesis of a potent beta-3 adrenoceptor agonist at the human receptor Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6 Synthesis and Evaluation of Potent and Selective β₃ Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres Discovery of Novel Indazole Derivatives as Orally Available β₃-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects